NIAID Archives -

A single dose of a monoclonal antibody developed by scientists at the US National Institutes of Health (NIH)

More malaria hope as NIH antibody protects against infection

https://pharmaphorum.com/news/more-malaria-hope-as-antibody-protects-against-infection/

AstraZeneca has been rebuked by a US health authority after a trial monitoring board said data published from

Doubts emerge over AZ’s ‘outdated’ US vaccine trial data

https://pharmaphorum.com/news/doubts-emerge-over-azs-outdated-us-vaccine-trial-data/

A promise by president-elect Joe Biden to carry out 100 million coronavirus vaccinations in his first 100 days

Fauci backs Biden’s plan for 100 million COVID-19 shots

https://pharmaphorum.com/news/fauci-backs-bidens-plan-for-100-million-covid-19-shots/

Eli Lilly’s Olumiant (baricitinib) has a significant effect on recovery from COVID-19 when combined with Gilead Veklury (remdesivir),

Eli Lilly and Gilead’s combination cuts COVID-19 recovery time

https://pharmaphorum.com/news/eli-lilly-and-gileads-combination-cuts-covid-19-recovery-time/

NIAID